Abstract
Chronic pain can cause problems with sleep, such as difficulty initiating and maintaining sleep. A potential benefit of opioid therapy is minimizing sleep problems by reducing pain. A 6-week, open-label, randomized, comparative, repeated-dose, parallel-group study was performed to characterize the efficacy, safety, and quality-of-life impact of once-daily OROS® hydromorphone and twice-daily ER oxycodone in 126 patients with chronic osteoarthritis (OA) pain of the knee or hip. All participants had been receiving long-term treatment with NSAIDs or another non-steroidal, non-opiod analgesic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
